Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
Dhruv S. Kazi, Andrew Edward Moran, Pamela G. Coxson, Joanne M. Penko, Daniel A. Ollendorf, Steven D. Pearson, Jeffrey A. Tice, David Guzman, Kirsten B. Bibbins-Domingo
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1001/jama.2016.11004
- Published
- Aug 16, 2016
- Venue
- JAMA
- DOI
- 10.1001/jama.2016.11004
- PubMed
- 27533159
- Categories
- Lipoproteins and Cardiovascular Health
- Provenance
- openalex